A family history of breast and ovarian cancers is reported in approximately 15%–20% of MBCs, and approximately 10% of MBC patients carry BRCA2 variants, while few patients carry the pathogenic variants of BRCA1 (4). This evidence concerns the gene BRCA2 and maternal uniparental disomy of chromosome 20.